Apical Pelvic Support in Infertility Patients

Sponsor
Uludag University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04039009
Collaborator
(none)
1,100
1
10
110.5

Study Details

Study Description

Brief Summary

This study aims to evaluate apical pelvic compartment support in infertility patients at the time of hysteroscopy. Apical pelvic compartment evaluation for pelvic organ prolapse will be performed in infertility patients undergoing hysteroscopy.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Pelvic Organ Prolapse Quantification system

Detailed Description

The incidence of pelvic organ prolapse in the whole population has been demonstrated several times in previous studies. However, pelvic floor defects in young infertility patients are not known. In this study, a clinical pelvic floor assessment with the pelvic organ quantification system will be performed in infertility patients during standard physical examinations or hysteroscopy.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Apical Pelvic Compartment Support in Infertility Patients
Actual Study Start Date :
Jan 1, 2019
Anticipated Primary Completion Date :
Sep 30, 2019
Anticipated Study Completion Date :
Oct 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Infertility patients

Infertility patients will be examined according to the pelvic organ prolapse quantification classification system during hysteroscopy.

Diagnostic Test: Pelvic Organ Prolapse Quantification system
The Pelvic Organ Prolapse Quantification system assessment tool measures nine anatomical points and distances in the vagina. The hymen is the reference point to which the other points are compared. The prolapsed organs are measured in centimeters to the hymen with an examination ruler.

Outcome Measures

Primary Outcome Measures

  1. Stages of the pelvic organ prolapse [2 minutes]

    Once the measurements are taken, the infertility patients are assigned to the corresponding POP-Q stage. Stage-0 is no prolapse. Stage-1 stands for the most distal portion of the prolapse is more than 1 cm above the level of the hymen. Stage-2 stands for the most distal prolapse is between 1 cm above and 1 cm below the hymen (at least one point is -1, 0, or +1). Stage-3: The most distal prolapse is more than 1 cm below the hymen but no further than 2 cm less than total vaginal length. Stage-4 stands for the complete vaginal eversion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
  • Ages between 18-45

  • Patients who cannot become pregnant despite regular sexual intercourse for more than one year

Exclusion Criteria:
  • Malignity

  • Patients who become pregnant during infertility assessment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uludag University Hospital, Department of Obstetrics and Gynecology Bursa Ozluce Turkey 16059

Sponsors and Collaborators

  • Uludag University

Investigators

  • Study Director: Gurkan Uncu, Prof., ULUDAG UNIVERSITY HOSPITAL BURSA TURKEY

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Adnan Orhan, Principal Investigator. Associate professor, Obstetrician and Gynecologist, Uludag University
ClinicalTrials.gov Identifier:
NCT04039009
Other Study ID Numbers:
  • UU-MREC-2019-9/22
First Posted:
Jul 31, 2019
Last Update Posted:
Aug 2, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Adnan Orhan, Principal Investigator. Associate professor, Obstetrician and Gynecologist, Uludag University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2019